Clinical trial
A Cluster Randomized Trial of Two Mask Systems (Acteev™ N95 + Acteev™ Fabric Masks vs. Standard N95 + Fabric Masks During Shifts & in Community) in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) in HCWs
NCT05036941 is registered in ClinicalTrials.gov with Ascend Performance Materials as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Cluster Randomized Trial of Two Mask Systems (Acteev™ N95 + Acteev™ Fabric Masks vs. Standard N95 + Fabric Masks During Shifts & in Community) in Preventing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV-2) in HCWs
- Lead sponsor
- Ascend Performance Materials
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 13, 2021
- Completion date
- February 28, 2022
- Enrollment
- 1,600 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
influenza -like illness, sars cov-2 infection